<DOC>
	<DOCNO>NCT00794443</DOCNO>
	<brief_summary>This multi-center double-blind parallel-group study involutional osteoporosis patient compare efficacy safety monthly oral intermittent formulation ONO-5920/YM529 daily formulation .</brief_summary>
	<brief_title>ONO-5920/YM529 Confirmatory Study Involutional Osteoporosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Patients whose bone mineral density &lt; 70 % Young Adult Mean ( YAM ) , &lt; 80 % YAM fragile fracture history Patients walk his/her Written inform consent obtain patient . Sequential osteoporosis patient patient disorder show low bone mass Patients finding influence measurement lumbar vertebral bone mineral density DXA method Patients unable keep raise stand â‰¥30 min Patients peptic ulcer Patients experience anamnesis gastrectomy ( total extraction )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>ONO-5920</keyword>
	<keyword>YM529</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Minodronic acid</keyword>
</DOC>